B
Biosency
Health Tech & Medtech · Saint-Grégoire, France · Founded 2017
Medical device company focused on developing smart healthcare solutions MoreLess
Biosency is a medical device company founded in 2018 and based in Cesson Sevigne, France. The company specializes in the development and commercialization of remote monitoring solutions for patients with chronic respiratory diseases.
Its main product is the Bora care® telemonitoring platform, a medical device (MD class 2a) that enables the remote monitoring of patients with respiratory failure. The platform is patient-centric and utilizes a connected photoplethysmogram (PPG) sensor to collect data. This data is then analyzed to provide real-world care management for chronic respiratory diseases. The company's business model is focused on providing these smart healthcare solutions to the telemonitoring and respiratory care sectors.
Keywords: medical devices, remote patient monitoring, respiratory care, telemonitoring, PPG sensor, chronic respiratory diseases, healthcare solutions, patient-centric, care management, medical data
Talent graph
Biosency's talent
Source: Dealroom Talent Intelligence.
Investors
2 investors on Biosency's cap table
Sourced from Dealroom's funding and investor records.
Global footprint
Where Biosency has talent and traffic
team presence
Market sentiment
What the market is saying about Biosency
An AI-synthesized read of the highest-engagement posts about Biosency on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Biosency on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.